Results:

Pharma Reputations: Managing Perceptions

14 08 2012

Geneva-based Covalence, a company that markets the information system, EthicalQuote, has observed that pharma is not keeping pace with other industries in terms of the overall balance of global good and bad news coverage in four broad ethical areas: labour standards, waste management, product social utility and human rights policy. “The pharma industry is losing […]


Private and Public Partners Unite to Combat 10 Neglected Tropical Diseases by 2020

30 01 2012

Today, 13 pharmaceutical companies, the U.S., U.K. and U.A.E governments, the Bill & Melinda Gates Foundation, the World Bank and other global health organisations announced a new, coordinated push to accelerate progress toward eliminating or controlling 10 neglected tropical diseases (NTDs) by the end of the decade. Uniting efforts with NTD-endemic countries, partners pledged to […]


Drug Firms Say They’ll Take Closer Look at the Docs They Pay

18 11 2010

Several of the nation’s largest pharmaceutical companies said they plan to tighten screening of physicians who promote their drugs after ProPublica reported last month that more than 250 of them had been sanctioned for misconduct. Eli Lilly and Co. said that next year, for the first time, it would hire an outside firm to search […]


Experimental breast cancer drug unethically tested on Indian women

5 02 2009

People in developing countries run health risks from pharmaceutical companies testing drugs on them for the Western market. An Indian research report published today again shows several pharmaceutical companies’ disregard for ethical rules. ‘The Indian Centre for Studies in Ethics and Rights has examined, among other things, the way GlaxoSmithKline tested a breast cancer drug […]


Pharmas Challenged by Product Risk and Philanthropy Fatigue – Covalence Pharmaceutical Industry Report 2008

9 09 2008

Increased attention on product human risk and smaller media coverage of drug donations have challenged Pharmaceuticals’ ethical reputation last year, states a report published today by Geneva-based research firm Covalence — Covalence Pharmaceutical Industry Report 2008. The pharmaceutical industry dropped from the first to the third rank of Covalence all-time EthicalQuote ranking across 10 industries. […]


Big drug companies raided in EU probe

17 01 2008

European regulators raided some of the world’s biggest pharmaceutical companies yesterday in an inquiry into whether they conspired to keep up the price of drugs after patents expired. Pfizer, GlaxoSmithKline, AstraZeneca and Sanofi-Aventis were among those that confirmed they had been visited as part of a European Commission-led probe into delays in the launch of […]


The Burden of Innovation – Covalence Pharmaceutical Industry Report 2007

29 08 2007

Pharmaceutical companies carry increasing ethical risks related to innovation, states a report released on 29 August 2007 by Geneva-based ethical reputation research firm Covalence, Covalence Pharmaceutical Industry Report 2007. These innovation-related risks deal with intellectual property rights, drug pricing, clinical trials, drug side-effects and transparency. In terms of ethical reputation, innovation seems to bring more […]


Wal-Mart, CIA, ExxonMobil Changed Wikipedia Entries

16 08 2007

A new Web site built by an American technology student has uncovered the lengths that companies apparently go to improve their public image by tweaking their entries on Wikipedia, the online encyclopedia that – famously – “anyone can edit.” The WikiScanner site, developed by Virgil Griffith, a researcher at the California Institute of Technology, reveals […]


After Sanctions, Doctors Get Drug Company Pay

3 06 2007

A decade ago the Minnesota Board of Medical Practice accused Dr. Faruk Abuzzahab of a “reckless, if not willful, disregard” for the welfare of 46 patients, 5 of whom died in his care or shortly afterward. The board suspended his license for seven months and restricted it for two years after that. But Dr. Abuzzahab, […]


GSK, BMS, J&J top ethical ranking list by Covalence

31 05 2007

GlaxoSmithKline is at the top of ethical-monitoring firm Covalence’s ranking list, followed by Bristol-Myers Squibb and Johnson & Johnson. The quarterly report, which ranks the top 10 highest-ranking pharmas, reveals that the amount of revenue a company earns does not necessarily correspond to its ethical reputation. Pfizer, the world’s highest revenue-generating drug company, only placed […]